Sodium ion binding proteins
AssigneeMount Sinai School of Medicine of the City University of New York
InventorsTerry A. Krulwich, D. Mack Ivey
Life of this patent
Estimating the term…
Loading patent…
AssigneeMount Sinai School of Medicine of the City University of New York
InventorsTerry A. Krulwich, D. Mack Ivey
Estimating the term…
The present invention relates to the cloning and expression of a sodium ion binding protein. In particular, the invention relates to cloning and expression of a nhaS gene. The nhaS gene product, NhaS, is a protein characterized by binding to and sequestering sodium ion (Na.sup.+). The invention further relates to functional fragments of a sodium ion binding protein, which fragments are characterized by their ability to bind to sodium ion. In a specific embodiment, the fragment is a fragment of NhaS. The gene encoding the sodium binding protein can be introduced into cells to produce desalination bioreactors. The gene encoding the sodium binding protein can also be introduced into plants as a transgene to produce plants that are resistant to sodium. The sodium binding protein itself may be used for treatments involving Na.sup.+ /K.sup.+ ATPase disorders, e.g., in heart disease; the protein also may be introduced parenterally, preferably orally, to bind to and sequester dietary sodium.
A purified and isolated DNA sequence selected from the group consisting of:
Dependencies are inferred from the claim text.